Form 4 holding
SVP Corp Dev & Gen Counsel
Onconova Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 24,514
- Estimated value
- $25,004
- Report date
- 28 Jan 2022
- Price
- $1.02
- Ownership
- Direct
Abraham N. Oler - SVP Corp Dev & Gen Counsel at Traws Pharma, Inc.
Issuer-level insider activity
- Role
- SVP Corp Dev & Gen Counsel
- Issuer ticker
- TRAW on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Abraham N. Oler since 06 Oct 2025
Reported holdings for Abraham N. Oler in Traws Pharma, Inc.
Form 4 holding
SVP Corp Dev & Gen Counsel
Onconova Therapeutics, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 17,633
- Estimated value
- $11,814
- Report date
- 07 Feb 2022
- Price
- $0.6700
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
Form 4 holding
SVP Corp Dev & Gen Counsel
Onconova Therapeutics, Inc.
- Security class
- Stock Option (right to purchase)
- Shares / value
- 54,050
- Estimated value
- Report date
- 07 Feb 2022
- Price
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
Transaction history for Abraham N. Oler in Traws Pharma, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.